Could a nausea drug tame blood pressure in sleep apnea?
NCT ID NCT06462287
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests whether a drug called aprepitant (currently used for nausea) can lower a hormone called aldosterone in people with severe sleep apnea and high blood pressure. The study will enroll 24 adults and measure aldosterone levels before and after taking the drug or a placebo. The goal is to understand if blocking a nerve signal in the adrenal gland can reduce blood pressure risks in sleep apnea.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APNEA, OBSTRUCTIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Rouen
RECRUITINGRouen, France, 76000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a heart drug be a new key to controlling high blood pressure?
- Which mouthpiece best keeps airways open during sleep? a Head-to-Head test
- A simple arm cuff may lower blood pressure without drugs
- AI tailors blood pressure drugs, outsmarting One-Size-Fits-All medicine
- Nerve zap in the neck could replace CPAP for sleep apnea
- Herbal capsule aims to tackle both high blood pressure and poor sleep